Early Salvage Radiation Therapy Does Not Compromise Cancer Control in Patients with pT3N0 Prostate Cancer After Radical Prostatectomy: Results of a Match-controlled Multi-institutional Analysis.

Briganti, Alberto;Wiegel, Thomas;Joniau, Steven;Cozzarini, Cesare;Van Poppel, Hein;et.al.
(2012) European Urology — Vol. 62, n° 3, p. 472-487 (2012)

Files

Briganti-2012-Earlysalvageradiation.pdf
  • Restricted Access
  • Adobe PDF
  • 2.16 MB
Request a copy

Details

Authors
  • Briganti, Alberto
    Author
  • Wiegel, Thomas
    Author
  • Joniau, Steven
    Author
  • Cozzarini, Cesare
    Author
  • Tombal, Bertrandorcid-logoUCLouvain
    Author
  • Van Poppel, Hein
    Author
Show more
Abstract
The current study suggests that timely administration of eSRT is comparable to aRT in improving BCR-free survival in the majority of pT3pN0 PCa patients. Therefore, eSRT may not compromise cancer control but significantly reduces overtreatment associated with aRT.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Briganti, A., Wiegel, T., Joniau, S., Cozzarini, C., Bianchi, M., Sun, M., Tombal, B., Haustermans, K., Budiharto, T., Hinkelbein, W., Di Muzio, N., Karakiewicz, P. I., Montorsi, F., & Van Poppel, H. (2012). Early Salvage Radiation Therapy Does Not Compromise Cancer Control in Patients with pT3N0 Prostate Cancer After Radical Prostatectomy: Results of a Match-controlled Multi-institutional Analysis. European Urology, 62(3), 472-487. https://doi.org/10.1016/j.eururo.2012.04.056 (Original work published 2012)